Cargando…
Author’s Reply to: “Comment on: Pharmacokinetics and Safety of Recombinant Human Interleukin-1 Receptor Antagonist GR007 in Chinese Healthy Subjects”
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746673/ https://www.ncbi.nlm.nih.gov/pubmed/31502082 http://dx.doi.org/10.1007/s13318-019-00574-8 |
| _version_ | 1783451725256982528 |
|---|---|
| author | Xie, Ran Zhang, Yang Zhao, Nan Zhou, Shuang Wang, Xin Han, Wei Yu, Yan Zhao, Xia Cui, Yimin |
| author_facet | Xie, Ran Zhang, Yang Zhao, Nan Zhou, Shuang Wang, Xin Han, Wei Yu, Yan Zhao, Xia Cui, Yimin |
| author_sort | Xie, Ran |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6746673 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Springer International Publishing |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-67466732019-09-30 Author’s Reply to: “Comment on: Pharmacokinetics and Safety of Recombinant Human Interleukin-1 Receptor Antagonist GR007 in Chinese Healthy Subjects” Xie, Ran Zhang, Yang Zhao, Nan Zhou, Shuang Wang, Xin Han, Wei Yu, Yan Zhao, Xia Cui, Yimin Eur J Drug Metab Pharmacokinet Letter to the Editor Springer International Publishing 2019-09-09 2019 /pmc/articles/PMC6746673/ /pubmed/31502082 http://dx.doi.org/10.1007/s13318-019-00574-8 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
| spellingShingle | Letter to the Editor Xie, Ran Zhang, Yang Zhao, Nan Zhou, Shuang Wang, Xin Han, Wei Yu, Yan Zhao, Xia Cui, Yimin Author’s Reply to: “Comment on: Pharmacokinetics and Safety of Recombinant Human Interleukin-1 Receptor Antagonist GR007 in Chinese Healthy Subjects” |
| title | Author’s Reply to: “Comment on: Pharmacokinetics and Safety of Recombinant Human Interleukin-1 Receptor Antagonist GR007 in Chinese Healthy Subjects” |
| title_full | Author’s Reply to: “Comment on: Pharmacokinetics and Safety of Recombinant Human Interleukin-1 Receptor Antagonist GR007 in Chinese Healthy Subjects” |
| title_fullStr | Author’s Reply to: “Comment on: Pharmacokinetics and Safety of Recombinant Human Interleukin-1 Receptor Antagonist GR007 in Chinese Healthy Subjects” |
| title_full_unstemmed | Author’s Reply to: “Comment on: Pharmacokinetics and Safety of Recombinant Human Interleukin-1 Receptor Antagonist GR007 in Chinese Healthy Subjects” |
| title_short | Author’s Reply to: “Comment on: Pharmacokinetics and Safety of Recombinant Human Interleukin-1 Receptor Antagonist GR007 in Chinese Healthy Subjects” |
| title_sort | author’s reply to: “comment on: pharmacokinetics and safety of recombinant human interleukin-1 receptor antagonist gr007 in chinese healthy subjects” |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746673/ https://www.ncbi.nlm.nih.gov/pubmed/31502082 http://dx.doi.org/10.1007/s13318-019-00574-8 |
| work_keys_str_mv | AT xieran authorsreplytocommentonpharmacokineticsandsafetyofrecombinanthumaninterleukin1receptorantagonistgr007inchinesehealthysubjects AT zhangyang authorsreplytocommentonpharmacokineticsandsafetyofrecombinanthumaninterleukin1receptorantagonistgr007inchinesehealthysubjects AT zhaonan authorsreplytocommentonpharmacokineticsandsafetyofrecombinanthumaninterleukin1receptorantagonistgr007inchinesehealthysubjects AT zhoushuang authorsreplytocommentonpharmacokineticsandsafetyofrecombinanthumaninterleukin1receptorantagonistgr007inchinesehealthysubjects AT wangxin authorsreplytocommentonpharmacokineticsandsafetyofrecombinanthumaninterleukin1receptorantagonistgr007inchinesehealthysubjects AT hanwei authorsreplytocommentonpharmacokineticsandsafetyofrecombinanthumaninterleukin1receptorantagonistgr007inchinesehealthysubjects AT yuyan authorsreplytocommentonpharmacokineticsandsafetyofrecombinanthumaninterleukin1receptorantagonistgr007inchinesehealthysubjects AT zhaoxia authorsreplytocommentonpharmacokineticsandsafetyofrecombinanthumaninterleukin1receptorantagonistgr007inchinesehealthysubjects AT cuiyimin authorsreplytocommentonpharmacokineticsandsafetyofrecombinanthumaninterleukin1receptorantagonistgr007inchinesehealthysubjects |